Your browser doesn't support javascript.
loading
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.
Nakagawa, Tomoyoshi; Kijima, Noriyuki; Hasegawa, Kana; Ikeda, Shunya; Yaga, Moto; Wibowo, Tansri; Tachi, Tetsuro; Kuroda, Hideki; Hirayama, Ryuichi; Okita, Yoshiko; Kinoshita, Manabu; Kagawa, Naoki; Kanemura, Yonehiro; Hosen, Naoki; Kishima, Haruhiko.
Affiliation
  • Nakagawa T; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kijima N; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hasegawa K; Laboratory of Cellular Immunotherapy, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Ikeda S; Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yaga M; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Wibowo T; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tachi T; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kuroda H; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hirayama R; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Okita Y; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kinoshita M; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kagawa N; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kanemura Y; Department of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Hosen N; Department of Neurosurgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Kishima H; Laboratory of Cellular Immunotherapy, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Neurooncol Adv ; 5(1): vdac177, 2023.
Article in En | MEDLINE | ID: mdl-36601313
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Neurooncol Adv Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Neurooncol Adv Year: 2023 Type: Article Affiliation country: Japan